These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10791367)
1. Brain natriuretic peptide as bridge to therapy for heart failure. Dries DL; Stevenson LW Lancet; 2000 Apr; 355(9210):1112-3. PubMed ID: 10791367 [No Abstract] [Full Text] [Related]
2. Analytical performance vs clinical use of natriuretic peptide measurements. Andrade DM; Vidigal PG; Eloi-Santos SM Arch Intern Med; 2010 Jul; 170(14):1274; author reply 1275. PubMed ID: 20660853 [No Abstract] [Full Text] [Related]
3. B-type natriuretic peptide in the management of patients with congestive heart failure. Menon PV; Glancy DL J La State Med Soc; 2004; 156(2):78-82. PubMed ID: 15106865 [No Abstract] [Full Text] [Related]
4. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment]. Dahlström U Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945 [No Abstract] [Full Text] [Related]
5. [Measurement of B-type natriuretic peptide in heart failure]. Meland E Tidsskr Nor Laegeforen; 2003 Nov; 123(21):3090. PubMed ID: 14618193 [No Abstract] [Full Text] [Related]
6. Role of the brain natriuretic peptide in heart failure management. Kalsmith BM Circ Heart Fail; 2009 Jul; 2(4):379. PubMed ID: 19808363 [No Abstract] [Full Text] [Related]
7. The challenges of properly identifying the cause of heart failure hospitalization. Ghali JK Arch Intern Med; 2010 Jul; 170(14):1274-5; author reply 1275. PubMed ID: 20660852 [No Abstract] [Full Text] [Related]
13. [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels]. Lindstedt G; Dahlström U; Fernlund P; Schaufelberger M; Stridsberg M Lakartidningen; 2001 Oct; 98(41):4444-8, 4450-2. PubMed ID: 11699251 [TBL] [Abstract][Full Text] [Related]
15. Prognosis in heart failure with a normal ejection fraction. Cleland JG; Taylor J; Tendera M N Engl J Med; 2007 Aug; 357(8):829-30. PubMed ID: 17715420 [No Abstract] [Full Text] [Related]
16. Complexity of molecular forms of B-type natriuretic peptide in heart failure. Nishikimi T; Kuwahara K; Nakagawa Y; Kangawa K; Minamino N; Nakao K Heart; 2013 May; 99(10):677-9. PubMed ID: 23118344 [No Abstract] [Full Text] [Related]
18. [Natriuretic cardiac hormones. Clinical use in heart failure]. Nielsen SJ; Gøtze JP; Raymond IE; Grønning BA; Kirk V; Bay-Nielsen M; Hildebrandt PR; Aldershvile J Ugeskr Laeger; 2004 Jan; 166(4):248-53. PubMed ID: 14964102 [No Abstract] [Full Text] [Related]
19. Natriuretic peptide-guided management by the general practitioner: how to interpret the SIGNAL. Drexler B; Mueller C Eur J Heart Fail; 2010 Dec; 12(12):1265-7. PubMed ID: 21098577 [No Abstract] [Full Text] [Related]
20. B-type natriuretic peptide as a marker of heart failure: Not so specific after all? Marshall W; Orlando R Crit Care Med; 2006 Aug; 34(8):2249. PubMed ID: 16883197 [No Abstract] [Full Text] [Related] [Next] [New Search]